BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11408498)

  • 1. Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.
    Bokemeyer C; Gillis AJ; Pompe K; Mayer F; Metzner B; Schleucher N; Schleicher J; Pflugrad-Jauch G; Oosterhuis JW; Kanz L; Looijenga LH
    J Clin Oncol; 2001 Jun; 19(12):3029-36. PubMed ID: 11408498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour.
    Vermeulen J; Ballet S; Oberlin O; Peter M; Pierron G; Longavenne E; Laurence V; Kanold J; Chastagner P; Lejars O; Blay JY; Marec-Berard P; Michon J; Delattre O; Schleiermacher G
    Br J Cancer; 2006 Nov; 95(10):1326-33. PubMed ID: 17088915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients.
    Kasahara T; Hara N; Bilim V; Tomita Y; Saito K; Obara K; Takahashi K
    Br J Cancer; 2001 Oct; 85(8):1119-23. PubMed ID: 11710823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Thomson B; Hawkins D; Felgenhauer J; Radich J
    Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.
    Kiel K; Cremer FW; Ehrbrecht E; Wallmeier M; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1998 Jun; 21(11):1109-15. PubMed ID: 9645573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of germ cell tumor cells in apheresis products using polymerase chain reaction.
    Fan Y; Einhorn L; Saxman S; Katz B; Abonour R; Cornetta K
    Clin Cancer Res; 1998 Jan; 4(1):93-8. PubMed ID: 9516957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
    Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture.
    Krüger WH; Stockschläder M; Hennings S; Aschenbrenner M; Gruber M; Gutensohn K; Löliger C; Gieseking F; Jonat W; Zander AR
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S18-20. PubMed ID: 8899163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of beta-human chorionic gonadotropin expressing cells by nested reverse transcriptase-polymerase chain reaction in the peripheral blood stem cells of patients with advanced germ cell tumor.
    Hara I; Yamada Y; Miyake H; Hara S; Gotoh A; Fujisawa M; Okada H; Arakawa S; Kamidono S
    J Urol; 2002 Mar; 167(3):1487-91. PubMed ID: 11832775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
    Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
    Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma.
    Burchill SA; Kinsey SE; Picton S; Roberts P; Pinkerton CR; Selby P; Lewis IJ
    Med Pediatr Oncol; 2001 Jan; 36(1):213-9. PubMed ID: 11464888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods.
    Testoni N; Lemoli RM; Martinelli G; Carboni C; Pelliconi S; Ottaviani E; Ruggeri D; Rizzi S; Motta MR; Visani G; Tura S
    Bone Marrow Transplant; 1998 Dec; 22(11):1065-70. PubMed ID: 9877268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
    Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
    Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors.
    Goeminne JC; Guillaume T; Salmon M; Machiels JP; D'Hondt V; Symann M
    Bone Marrow Transplant; 1999 Oct; 24(7):769-75. PubMed ID: 10516681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients.
    Corrias MV; Haupt R; Carlini B; Parodi S; Rivabella L; Garaventa A; Pistoia V; Dallorso S
    Clin Cancer Res; 2006 Oct; 12(19):5680-5. PubMed ID: 17020970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
    J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.